Creative Planning’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-6,262
| Closed | -$325K | – | 1737 |
|
2019
Q4 | $325K | Buy |
6,262
+8
| +0.1% | +$415 | ﹤0.01% | 1352 |
|
2019
Q3 | $343K | Sell |
6,254
-8,944
| -59% | -$491K | ﹤0.01% | 1267 |
|
2019
Q2 | $617K | Hold |
15,198
| – | – | ﹤0.01% | 958 |
|
2019
Q1 | $460K | Buy |
15,198
+1,290
| +9% | +$39K | ﹤0.01% | 1074 |
|
2018
Q4 | $467K | Buy |
13,908
+3,704
| +36% | +$124K | ﹤0.01% | 996 |
|
2018
Q3 | $430K | Hold |
10,204
| – | – | ﹤0.01% | 1169 |
|
2018
Q2 | $327K | Sell |
10,204
-13
| -0.1% | -$417 | ﹤0.01% | 1312 |
|
2018
Q1 | $508K | Buy |
10,217
+1,988
| +24% | +$98.8K | ﹤0.01% | 1064 |
|
2017
Q4 | $444K | Buy |
+8,229
| New | +$444K | ﹤0.01% | 1138 |
|
2017
Q3 | – | Sell |
-1,004
| Closed | -$50K | – | 1929 |
|
2017
Q2 | $50K | Sell |
1,004
-50
| -5% | -$2.49K | ﹤0.01% | 2488 |
|
2017
Q1 | $46K | Buy |
1,054
+50
| +5% | +$2.18K | ﹤0.01% | 2512 |
|
2016
Q4 | $49K | Buy |
1,004
+4
| +0.4% | +$195 | ﹤0.01% | 2385 |
|
2016
Q3 | $48K | Sell |
1,000
-86
| -8% | -$4.13K | ﹤0.01% | 2371 |
|
2016
Q2 | $58K | Sell |
1,086
-414
| -28% | -$22.1K | ﹤0.01% | 2019 |
|
2016
Q1 | $67K | Buy |
1,500
+200
| +15% | +$8.93K | ﹤0.01% | 1882 |
|
2015
Q4 | $50K | Buy |
1,300
+300
| +30% | +$11.5K | ﹤0.01% | 2094 |
|
2015
Q3 | $32K | Buy |
+1,000
| New | +$32K | ﹤0.01% | 2353 |
|
2015
Q2 | – | Sell |
-1,000
| Closed | -$41K | – | 1141 |
|
2015
Q1 | $41K | Hold |
1,000
| – | – | ﹤0.01% | 2138 |
|
2014
Q4 | $41K | Sell |
1,000
-22
| -2% | -$902 | ﹤0.01% | 2117 |
|
2014
Q3 | $37K | Buy |
1,022
+22
| +2% | +$796 | ﹤0.01% | 2108 |
|
2014
Q2 | $46K | Hold |
1,000
| – | – | ﹤0.01% | 1901 |
|
2014
Q1 | $41K | Sell |
1,000
-300
| -23% | -$12.3K | ﹤0.01% | 1915 |
|
2013
Q4 | $50K | Sell |
1,300
-518
| -28% | -$19.9K | ﹤0.01% | 1605 |
|
2013
Q3 | $43K | Buy |
1,818
+818
| +82% | +$19.3K | ﹤0.01% | 1598 |
|
2013
Q2 | $17K | Buy |
+1,000
| New | +$17K | ﹤0.01% | 2015 |
|